These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1074 related articles for article (PubMed ID: 16288365)
1. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365 [TBL] [Abstract][Full Text] [Related]
2. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623 [TBL] [Abstract][Full Text] [Related]
3. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Helms DJ; Mosure DJ; Metcalf CA; Douglas JM; Malotte CK; Paul SM; Peterman TA Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314 [TBL] [Abstract][Full Text] [Related]
5. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203 [TBL] [Abstract][Full Text] [Related]
6. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. Van Der Pol B; Kwok C; Pierre-Louis B; Rinaldi A; Salata RA; Chen PL; van de Wijgert J; Mmiro F; Mugerwa R; Chipato T; Morrison CS J Infect Dis; 2008 Feb; 197(4):548-54. PubMed ID: 18275275 [TBL] [Abstract][Full Text] [Related]
7. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria. Konje JC; Otolorin EO; Ogunniyi JO; Obisesan KA; Ladipo OA Afr J Med Med Sci; 1991 Mar; 20(1):29-34. PubMed ID: 1905467 [TBL] [Abstract][Full Text] [Related]
9. Trichomoniasis and its treatment. Nanda N; Michel RG; Kurdgelashvili G; Wendel KA Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214 [TBL] [Abstract][Full Text] [Related]
10. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. Klebanoff MA; Carey JC; Hauth JC; Hillier SL; Nugent RP; Thom EA; Ernest JM; Heine RP; Wapner RJ; Trout W; Moawad A; Leveno KJ; Miodovnik M; Sibai BM; Van Dorsten JP; Dombrowski MP; O'Sullivan MJ; Varner M; Langer O; McNellis D; Roberts JM; N Engl J Med; 2001 Aug; 345(7):487-93. PubMed ID: 11519502 [TBL] [Abstract][Full Text] [Related]
11. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations. Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417 [TBL] [Abstract][Full Text] [Related]
12. Premature with trichomoniasis: report of one case. Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336 [TBL] [Abstract][Full Text] [Related]
13. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Klinger EV; Kapiga SH; Sam NE; Aboud S; Chen CY; Ballard RC; Larsen U Sex Transm Dis; 2006 Dec; 33(12):712-8. PubMed ID: 16755271 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678 [TBL] [Abstract][Full Text] [Related]
15. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Seña AC; Bachmann LH; Hobbs MM Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study. Piperaki ET; Theodora M; Mendris M; Barbitsa L; Pitiriga V; Antsaklis A; Tsakris A J Clin Pathol; 2010 Mar; 63(3):249-53. PubMed ID: 20203225 [TBL] [Abstract][Full Text] [Related]
17. Management of metronidazole-resistant Trichomonas vaginalis--a new approach. Mammen-Tobin A; Wilson JD Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628 [TBL] [Abstract][Full Text] [Related]
18. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Cherpes TL; Wiesenfeld HC; Melan MA; Kant JA; Cosentino LA; Meyn LA; Hillier SL Sex Transm Dis; 2006 Dec; 33(12):747-52. PubMed ID: 16691155 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of Trichomonas vaginalis infections in women participating in a clinical trial in Durban, South Africa. Naidoo S; Wand H Sex Transm Infect; 2013 Sep; 89(6):519-22. PubMed ID: 23605853 [TBL] [Abstract][Full Text] [Related]
20. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]